Steven Grinspoon, MD, on Targeting Endocrine Pathways in NAFLD
In this podcast,\xa0Steven Grinspoon, MD, discusses his session on endocrine pathways and therapeutic options for patients with nonalcoholic fatty liver disease, which he presented at Harvard University\u2019s 21st Annual Symposium on NAFLD. More at: www.consultant360.com/gastroenterology